Eg5 is also upregulated in different CNS tumors, with a great extent for gliomas and the highest grade of glioma, glioblastoma (GBM), thus shedding light on the possibility of using this kinesin as a new possible target. The gene discussed is KIF11; the disease is central nervous system neoplasm.